167 related articles for article (PubMed ID: 23451808)
1. Acute generalized exanthematous pustulosis induced by levetiracetam.
Lee YY; Ko JH; Chung WH
Int J Dermatol; 2014 Jan; 53(1):e5-6. PubMed ID: 23451808
[No Abstract] [Full Text] [Related]
2. Acute generalized exanthematous pustulosis secondary to levetiracetam and valproic acid use.
Levy ZD; Slowey M; Schulder M
Am J Emerg Med; 2017 Jul; 35(7):1036.e1-1036.e2. PubMed ID: 28189379
[TBL] [Abstract][Full Text] [Related]
3. [Acute generalized exanthematous pustulosis. Study of 22 cases].
Mebazaa A; Kort R; Zaiem A; Elleuch D; Moula H; Cheikhrouhou R; Trojjet S; Mokni M; Ben Osman A; Daghfous R
Tunis Med; 2010 Dec; 88(12):910-5. PubMed ID: 21136359
[TBL] [Abstract][Full Text] [Related]
4. Levetiracetam-induced thrombocytopenia.
Kimland E; Höjeberg B; von Euler M
Epilepsia; 2004 Jul; 45(7):877-8. PubMed ID: 15230717
[No Abstract] [Full Text] [Related]
5. Drug points: Weight loss associated with levetiracetam.
Hadjikoutis S; Pickersgill TP; Smith PE
BMJ; 2003 Oct; 327(7420):905. PubMed ID: 14563748
[No Abstract] [Full Text] [Related]
6. Hypersexuality in a patient with epilepsy during treatment of levetiracetam.
Metin SZ; Ozmen M; Ozkara C; Ozmen E
Seizure; 2013 Mar; 22(2):151-2. PubMed ID: 23200413
[No Abstract] [Full Text] [Related]
7. Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report.
Almeida DM; Jean MR; Chystsiakova A; Monahan E; Oliveira SB; Monteiro IM
Pancreas; 2013 Jan; 42(1):177-8. PubMed ID: 23254916
[No Abstract] [Full Text] [Related]
8. Nystatin-induced acute generalized exanthematous pustulosis.
Ocerin-Guerra I; Gomez-Bringas C; Aspe-Unanue L; Ratón-Nieto JA
Actas Dermosifiliogr; 2012 Dec; 103(10):927-8. PubMed ID: 23149047
[No Abstract] [Full Text] [Related]
9. HLA-B*5701 and HLA-B*5801 in an Indian patient with anti-epileptics induced cutaneous adverse drug reactions.
Manoharan A; Kumar AS; Sreedevi A; Sathishkannan AD; Gaddam BK
Eur J Clin Pharmacol; 2019 Apr; 75(4):599-601. PubMed ID: 30607451
[No Abstract] [Full Text] [Related]
10. Levetiracetam, seizures, and suicidality.
Givon L; Porter S; Padmanabhan B; Goren J; Cohen PA
Harv Rev Psychiatry; 2011; 19(1):47-55. PubMed ID: 21250896
[No Abstract] [Full Text] [Related]
11. The place of levetiracetam in the treatment of epilepsy.
Leppik IE
Epilepsia; 2001; 42 Suppl 4():44-5. PubMed ID: 11564126
[No Abstract] [Full Text] [Related]
12. Acute generalized exanthematous pustulosis induced by galantamine.
Pérez-García MP; Sánchez-Motillas JM; Mateu-Puchades A; Díaz-Corpas T
Actas Dermosifiliogr; 2013 Dec; 104(10):930-1. PubMed ID: 23260878
[No Abstract] [Full Text] [Related]
13. Encephalopathy induced by levetiracetam added to valproate.
Bauer J
Acta Neurol Scand; 2008 May; 117(5):374-6. PubMed ID: 18081909
[TBL] [Abstract][Full Text] [Related]
14. Levetiracetam-induced psychosis in a pregnant woman with prior substance abuse.
Bui M; Baslet G; Weisholtz D; McElrath T
Harv Rev Psychiatry; 2014; 22(3):193-200. PubMed ID: 24802726
[No Abstract] [Full Text] [Related]
15. Hyponatremia associated with repeated use of levetiracetam.
Nasrallah K; Silver B
Epilepsia; 2005 Jun; 46(6):972-3. PubMed ID: 15946344
[TBL] [Abstract][Full Text] [Related]
16. Levetiracetam as a possible cause of fulminant liver failure.
Tan TC; de Boer BW; Mitchell A; Delriviere L; Adams LA; Jeffrey GP; Macquillan G
Neurology; 2008 Aug; 71(9):685-6. PubMed ID: 18725594
[No Abstract] [Full Text] [Related]
17. [Probable levetiracetam-induced psychosis].
Roig J; Carreño MM; Parellada E
Med Clin (Barc); 2007 Jul; 129(7):278. PubMed ID: 17683712
[No Abstract] [Full Text] [Related]
18. Levetiracetam-induced diffuse interstitial lung disease.
Newsome SD; Xue LY; Jennings T; Castaneda GY
J Child Neurol; 2007 May; 22(5):628-30. PubMed ID: 17690072
[TBL] [Abstract][Full Text] [Related]
19. Acute generalized exanthematous pustulosis during antituberculosis therapy.
Cantisani C; Paradisi A; Richetta AG; Mattozzi C; Calvieri S
Clin Ter; 2013; 164(2):e137-8. PubMed ID: 23698216
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
Li S; Cao J; Xiao N; Cai F
J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
